Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Devaraj

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Health Technology Assessment (Winchester, England)|May 26, 2016
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancerJohn K Field, Stephen W Duffy, David R Baldwin, et al.
British Journal of Cancer|November 6, 2023
Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosisBenjamin Hunter, Christos Argyros, Marianna Inglese, et al.
The Lancet. Oncology|May 4, 2023
Defining the road map to a UK national lung cancer screening programmeEmma L O'Dowd, Richard W Lee, Ahsan R Akram, et al.
BMJ Open Respiratory Research|September 11, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screeningBrintha Selvarajah, Amyn Bhamani, Mehran Azimbagirad, et al.
The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.
The European Respiratory Journal|October 6, 2023
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma L O'Dowd, Ilona Tietzova, Emily Bartlett, et al.
Annals of the American Thoracic Society|March 23, 2026
Age, sex, smoking-specific prevalence and progression in interstitial lung abnormality: patient-level meta-analysisKum Ju Chae, Hyunsook Hong, Claire C Cutting, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 7, 2023
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma L O'Dowd, Ilona Tietzova, Emily Bartlett, et al.
The Lancet. Oncology|March 28, 2025
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese, et al.
Cancers|July 1, 2020
Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in EuropeGiulia Veronesi, David R Baldwin, Claudia I Henschke, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Health Technology Assessment (Winchester, England)|May 26, 2016
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancerJohn K Field, Stephen W Duffy, David R Baldwin, et al.
British Journal of Cancer|November 6, 2023
Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosisBenjamin Hunter, Christos Argyros, Marianna Inglese, et al.
The Lancet. Oncology|May 4, 2023
Defining the road map to a UK national lung cancer screening programmeEmma L O'Dowd, Richard W Lee, Ahsan R Akram, et al.
BMJ Open Respiratory Research|September 11, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screeningBrintha Selvarajah, Amyn Bhamani, Mehran Azimbagirad, et al.
The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.
The European Respiratory Journal|October 6, 2023
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma L O'Dowd, Ilona Tietzova, Emily Bartlett, et al.
Annals of the American Thoracic Society|March 23, 2026
Age, sex, smoking-specific prevalence and progression in interstitial lung abnormality: patient-level meta-analysisKum Ju Chae, Hyunsook Hong, Claire C Cutting, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 7, 2023
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma L O'Dowd, Ilona Tietzova, Emily Bartlett, et al.
The Lancet. Oncology|March 28, 2025
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese, et al.
Cancers|July 1, 2020
Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in EuropeGiulia Veronesi, David R Baldwin, Claudia I Henschke, et al.
Pageof 18